MicroRNA-122 expression in hepatotoxic and γ-irradiated rats pre-treated with naringin and silymarin

被引:6
|
作者
Marzook, E. Abdelmageed [1 ]
Abdel-Aziz, A. F. [2 ]
Abd El-Moneim, A. E. [1 ]
Mansour, H. A. [1 ]
Atia, K. S. [1 ]
Salah, N. A. [2 ]
机构
[1] Atom Energy Author, Nucl Res Ctr, Biol Applicat Dept, Cairo, Egypt
[2] Mansura Univ, Fac Sci, Dept Chem, Mansoura, Egypt
关键词
MicroRNA-122; hepatotoxicity; Naringin; silymarin; gamma radiation; radioprotective; MICRO-RNA EXPRESSION; CARBON-TETRACHLORIDE; IONIZING-RADIATION; INDUCED TOXICITY; IN-VIVO; LIVER; DAMAGE; MELATONIN; RADIOTHERAPY; INHIBITION;
D O I
10.1080/16878507.2019.1695392
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Recently, the fundamental roles of microRNAs (miRNAs) in the progression and development of diseases have been shown in several studies. In the liver 70% of all expressed miRNAs is miR-122; therefore it is measured as a liver-specific miRNA. The aim of this work was to evaluate the hepatoprotective and radioprotective effect of orally administrated naringin and silymarin pre-treatment in CCl4-intoxicated and gamma-irradiated rats, also to study the change of gene expression of microRNA and change of IL-6 levels to find powerful and reliable tools that can be used as a biomarker for the diagnosis of hepatotoxicity and radiation exposure for monitoring and treatment. This study revealed that pre-treatment of rats with naringin orally (80 mg/kg b,w) significantly restored the levels of superoxide dismutase (SOD), lipid peroxidation (MDA) and reduced glutathione (GSH) in rats injected with 1 ml/kg b.wi.p CCl4 and in rats exposed to 7 Gray single one shot dose of gamma radiations. The combination between naringin and silymarin resulted in significant reduction in IL-6 level in hepatotoxic rats. MicroRNA-122 expression changes in hepatotoxicity and radiation emphasize the great value of miRNA signatures as hepatotoxicity and radiation biomarker.
引用
收藏
页码:47 / 55
页数:9
相关论文
共 50 条
  • [21] Expression of blood hepatocyte-derived microRNA-122 in canine multicentric lymphoma with hepatic involvement
    Eman S. Ramadan
    Adel Abdelbaset Kubesy
    Taher Ahmed Baraka
    Faisal Abdelsamad Torad
    Shaymaa Ismaiel Salem
    Noha Yousef Salem
    Veterinary Research Communications, 2019, 43 : 231 - 238
  • [22] MicroRNA expression in ACTH-producing pituitary tumors: up-regulation of microRNA-122 and -493 in pituitary carcinomas
    Gail Stilling
    Zhifu Sun
    Shuya Zhang
    Long Jin
    Alberto Righi
    Gάbor Kovācs
    Mάrta Korbonits
    Bernd W. Scheithauer
    Kalman Kovacs
    Ricardo V. Lloyd
    Endocrine, 2010, 38 : 67 - 75
  • [24] Increased expression of microRNA-122, microRNA-146a and microRNA-155 in intestinal mucosa of pediatric patients with Crohn's disease
    Beres, N. J.
    Szabo, D.
    Arato, A.
    Kiss, A.
    Lendvai, G.
    Veres, G.
    JOURNAL OF CROHNS & COLITIS, 2014, 8 : S87 - S87
  • [25] Serum exosomal microRNA-122 and microRNA-21 as predictive biomarkers in transarterial chemoembolization-treated hepatocellular carcinoma patients
    Suehiro, Tomoyuki
    Miyaaki, Hisamitsu
    Kanda, Yasuko
    Shibata, Hidetaka
    Honda, Takuya
    Ozawa, Eisuke
    Miuma, Satoshi
    Taura, Naota
    Nakao, Kazuhiko
    ONCOLOGY LETTERS, 2018, 16 (03) : 3267 - 3273
  • [26] MICRORNA-130 AND MICRORNA-122 ALTERATION ARE RELATED TO LIPID METABOLIC IMPAIRMENTS IN THE FOETAL LIVER OF RATS WITH GESTATIONAL DIABETES MELLITUS
    Fornes, D.
    White, V.
    Heinecke, F.
    Capobianco, E.
    Jawerbaum, A.
    PLACENTA, 2017, 51 : 123 - 123
  • [27] Elevating microRNA-122 in blood improves outcomes after temporary middle cerebral artery occlusion in rats
    Liu, Da Zhi
    Jickling, Glen C.
    Ander, Bradley P.
    Hull, Heather
    Zhan, Xinhua
    Cox, Christopher
    Shroff, Natasha
    Dykstra-Aiello, Cheryl
    Stamova, Boryana
    Sharp, Frank R.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2016, 36 (08): : 1374 - 1383
  • [28] Expression of MicroRNA-122 in Hepatocellular Carcinomas Arising from Patients with Different Underlying Chronic Liver Diseases
    Byrnes, Kathleen
    Zhang, Jinqiang
    Han, Chang
    Wu, Tong
    HEPATOLOGY, 2012, 56 : 627A - 627A
  • [29] ACUTE TOLERANCE IN ETOH NAIVE AND ETOH PRE-TREATED RATS
    HILTUNEN, AJ
    JARBE, TUC
    PSYCHOPHARMACOLOGY, 1990, 101 : S69 - S69
  • [30] PHARMACOLOGIC CHARACTERIZATION OF RESERPINE RESPONSES IN RATS PRE-TREATED WITH IPRONIAZID
    FRANCOBROWDER, S
    MASSON, GMC
    CORCORAN, AC
    PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1958, 97 (04): : 778 - 780